Dimethylmethoxy Chromanol: Ingufu zirwanya okisidasiyo zivugurura ubwitabire bw'uruhu n'udushya mu buvuzi

Ikinyabutabire gisanzwe kiboneka mu bimera no mu binyabuzima byo mu mazi, chromanol (2,2-dimethyl-6-methoxychroman-4-ol) kiri kugaragara nk'ikintu cy'ingenzi mu bushakashatsi bwa siyansi. Iterambere riherutse gukorwa mu ikoranabuhanga ryo gukuramo no gukora ibintu birimo gutuma ihinduka mu bimera, mu miti no mu bumenyi bw'ibiribwa, rituma ihinduka.

Imiterere yihariye ya Chromanol - impeta ya chromane ifite amatsinda ya methoxy na hydroxyl - itanga ubushobozi budasanzwe bwo gushakisha radicals zidafite ireme. Ubushakashatsi bwasohotse muri Antioxidants bwerekana ko igabanya amoko ya ogisijeni (ROS) inshuro 3-5 kurusha Vitamine E, bigatuma iba uburyo bwiza bwo gukoresha imiti ishobora kwangirika.
Porogaramu z'ingenzi n'amakuru agezweho
Iterambere ry'indwara z'uruhu
Ubushakashatsi bwakozwe muri Kaminuza y’Igihugu ya Seoul mu 2025 bwagaragaje ubushobozi bwa chromanol bwo kugabanya imikorere ya MMP-1 collagenase ku kigero cya 72%, bigabanya iminkanyari mu ruhu rwahindutse ifoto.
Guhuza nanotechnology byakemuye ibibazo byo gushonga, bituma serum na creams bitangwa neza ku kigero cya 90%.
Ingufu z'ubuvuzi
Abashakashatsi bo muri Koch Institute ya MIT bavumbuye ko chromanol igabanya imbaraga za NLRP3 mu gutera ubushyuhe, igaragaza ko ifite akamaro mu kugabanya indwara ziterwa no kubyimba nka atherosclerosis.
Igeragezwa ryakozwe mbere y’uko ubuvuzi butangira rigaragaza ko rishobora kurinda uturemangingo twa β twa pancreas, ritanga ingamba nshya zo kuvura diyabete.
Kubungabunga ibiribwa
Ikigo gishinzwe umutekano w’ibiribwa mu muryango w’ubumwe bw’ibihugu by’uburayi (EFSA) cyemeje chromanol nk'umuti urinda ibiryo mu buryo karemano mu 2024, wongera igihe cyo kumara ibikomoka ku mafi ku kigero cya 50% mu gihe ukomeza kugira intungamubiri.
Udushya mu bya tekiniki
Abahanga mu bya siyansi bakoze uburyo bwo gukora enzymes kugira ngo bakore chromanol ku rwego rw'inganda, bigabanya ikiguzi ku kigero cya 60% ugereranije n'uburyo gakondo bwo kuyikuramo. Imiti ifite uburenganzira bwo gukoresha cyclodextrin encapsulation yongera ubushyuhe, bigatuma ikoreshwa mu bushyuhe bwinshi nko mu biryo bitetse.
“Chromanol igaragaza impinduka mu bumenyi bw’ibirwanya ogisijeni,” Dr. Clara Lopez, umuyobozi w’ishami ry’ubwiza muri ETH Zurich yagize ati: “Ifite imikorere myinshi ihuza icyuho kiri hagati yo kwita ku ruhu no kuvura.”

Biteganijwe ko chromanol izakenera ku isi yose izagera kuri miliyoni 850 z'amadolari mu 2030, bitewe nuko ikoreshwa mu bikoresho by'ubwiza n'intungamubiri. Ubushakashatsi buri gukorwa bugaragaza uruhare rwayo mu gukumira indwara ziterwa n'imitsi no gupfunyika ibikoresho bidafite ingaruka ku bidukikije.